BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 29572571)

  • 1. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
    Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
    J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.
    Veselý B; Rektor I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
    Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
    Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with parkinson's disease? A systematic review and meta-analysis.
    Carvalho de Abreu DC; Pieruccini-Faria F; Son S; Montero-Odasso M; Camicioli R
    Neurosci Biobehav Rev; 2024 Jun; 161():105677. PubMed ID: 38636832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.
    Veselý B; Antonini A; Rektor I
    J Neural Transm (Vienna); 2016 Mar; 123(3):241-50. PubMed ID: 26483133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1.
    Stefanova E; Žiropadja L; Stojković T; Stanković I; Tomić A; Ječmenica-Lukić M; Petrović I; Kostić V
    Dement Geriatr Cogn Disord; 2015; 40(3-4):199-209. PubMed ID: 26226988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.
    Chondrogiorgi M; Astrakas LG; Zikou AK; Weis L; Xydis VG; Antonini A; Argyropoulou MI; Konitsiotis S
    Brain Imaging Behav; 2019 Feb; 13(1):232-240. PubMed ID: 29629498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
    Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
    Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
    Goldman JG; Weis H; Stebbins G; Bernard B; Goetz CG
    Mov Disord; 2012 Aug; 27(9):1129-36. PubMed ID: 22778009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.